Search - tctmd.com

Displaying 81 - 100 of 171

Sort: Relevancy | Date

News Daily News

More Blood-Pressure Drugs Recalled Due to Cancer-Causing Impurities

Shelley Wood

December 10, 2018

News Daily News

FDA Warns of Stroke and Arterial Dissection Risk With MS Drug

L.A. McKeown

November 29, 2018

News Daily News

FDA Touts Increased Oversight of Medical Device Makers

Michael O'Riordan

November 22, 2018

News Conference News AHA 2018

VITAL: No Benefits to Vitamin D and Omega-3s in Reducing Major CV Events, Cancer

Shelley Wood

November 10, 2018

News Daily News

Diabetes Drug Canagliflozin Gets MACE Reduction Indication

Todd Neale

November 01, 2018

News Daily News

FDA: All AFX Endovascular AAA Systems Now Under Class I Recall

L.A. McKeown

October 16, 2018

FDA Warns of Deaths, Stroke With Latest-Generation Total Artificial Heart

News Daily News

FDA Warns of Deaths, Stroke Due to Power System Problems With Total Artificial Heart System

Lucy Hicks

August 17, 2018

News Daily News

Implantable Cardiac Monitor for High-Risk ACS Patients Wins FDA Approval

Michael O'Riordan

May 08, 2018

News Daily News

Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval

Todd Neale

May 04, 2018

News Industry News

First of Its Kind Technology Reduces Stroke by More Than 60 Percent in Patients Undergoing Common Heart Procedure

May 02, 2018

News Daily News

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Michael O'Riordan

April 25, 2018

News Daily News

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

Michael O'Riordan

April 24, 2018

News Conference News ACC 2018

Bad BVS News: Analysis Points to Fast Reaction by Interventionalists to Absorb Safety Issues

Michael O'Riordan

March 11, 2018

News Daily News

FDA: Clarithromycin Risks Persist in Patients With CAD

Todd Neale

February 26, 2018

News Daily News

FDA Warns Certain Zoll LifeVests Might Fail to Deliver Shocks

Michael O'Riordan

January 17, 2018

News Daily News

Recall: Clopidogrel Tablets Mislabeled, May Contain Statin

L.A. McKeown

January 11, 2018

News Daily News

Biotin Supplements Can Interfere With Cardiac Troponin Tests: FDA

Michael O'Riordan

November 28, 2017

News Conference News AHA 2017

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

Michael O'Riordan

November 17, 2017

News Conference News AHA 2017

GEMINI-ACS-1 Substudy: P2Y12 Inhibitor Switching Is Uncommon After ACS

Yael L. Maxwell

November 14, 2017

News Daily News

Statins and Diabetes: Causal Link Reinforced in New Analysis

Michael O'Riordan

October 25, 2017

Advertisement

More Blood-Pressure Drugs Recalled Due to Cancer-Causing Impurities

FDA Warns of Stroke and Arterial Dissection Risk With MS Drug

FDA Touts Increased Oversight of Medical Device Makers

VITAL: No Benefits to Vitamin D and Omega-3s in Reducing Major CV Events, Cancer

Diabetes Drug Canagliflozin Gets MACE Reduction Indication

FDA: All AFX Endovascular AAA Systems Now Under Class I Recall

FDA Warns of Deaths, Stroke Due to Power System Problems With Total Artificial Heart System

Implantable Cardiac Monitor for High-Risk ACS Patients Wins FDA Approval

Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval

First of Its Kind Technology Reduces Stroke by More Than 60 Percent in Patients Undergoing Common Heart Procedure

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

Bad BVS News: Analysis Points to Fast Reaction by Interventionalists to Absorb Safety Issues

FDA: Clarithromycin Risks Persist in Patients With CAD

FDA Warns Certain Zoll LifeVests Might Fail to Deliver Shocks

Recall: Clopidogrel Tablets Mislabeled, May Contain Statin

Biotin Supplements Can Interfere With Cardiac Troponin Tests: FDA

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

GEMINI-ACS-1 Substudy: P2Y12 Inhibitor Switching Is Uncommon After ACS

Statins and Diabetes: Causal Link Reinforced in New Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content